Market Overview

Argos Therapeutics (NASDAQ: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2018
After-Hours
EPS:
REV:
-0.13
53.497K

50K
-0.47
1.248M

2396%
Q2 2018
After-Hours
EPS:
REV:
-0.21
69.693K

50K
-0.61
54.247K

8.49%
Q1 2018
After-Hours
EPS:
REV:
-0.58
105.259K
-1.80
50K
-0.28
5.933M
-84.44%
11766%
Q4 2017
Pre-Market
EPS:
REV:

-1.40
50K
-1.05
1.671M
-25%
3242%
Q3 2017
After-Hours
EPS:
REV:
-0.32
146.756K
-0.20
100K
-0.13
53.497K
-35%
-46.5%
Q2 2017
After-Hours
EPS:
REV:
-0.48
488.643K
-0.26
100K
-0.21
69.693K
-19.23%
-30.31%
Q1 2017
After-Hours
EPS:
REV:
-0.57
146.429K
-0.36
130K
-0.58
105.259K
61.11%
-19.03%
Q4 2016
After-Hours
EPS:
REV:
-0.84
73.818K
-0.26
100K
-0.36
163.64K
38.46%
63.64%
Q3 2016
Pre-Market
EPS:
REV:
-0.97
158.349K
-0.35
250K
-0.32
146.756K
-937.5%
7035.08%
Q2 2016
After-Hours
EPS:
REV:
-0.95
107.391K
-0.43
200K
-0.48
488.643K
-11.63%
144.32%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!